Bradley & Co. Private Wealth Management LLC Purchases New Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Bradley & Co. Private Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 245 shares of the financial services provider’s stock, valued at approximately $32,000.

Several other hedge funds also recently added to or reduced their stakes in IBB. BNP Paribas Financial Markets increased its stake in iShares Biotechnology ETF by 29.3% during the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after purchasing an additional 538,899 shares during the last quarter. Commerce Bank grew its position in shares of iShares Biotechnology ETF by 1.8% during the 3rd quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock valued at $108,234,000 after buying an additional 12,921 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its stake in iShares Biotechnology ETF by 32.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after acquiring an additional 164,000 shares during the period. Main Management ETF Advisors LLC lifted its holdings in iShares Biotechnology ETF by 2.5% in the third quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock worth $86,395,000 after acquiring an additional 14,535 shares during the last quarter. Finally, Gray Foundation boosted its stake in iShares Biotechnology ETF by 25.2% in the fourth quarter. Gray Foundation now owns 164,872 shares of the financial services provider’s stock valued at $21,798,000 after acquiring an additional 33,179 shares during the period. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Down 0.6 %

NASDAQ:IBB opened at $137.86 on Wednesday. The stock has a 50 day moving average of $135.64 and a 200-day moving average of $140.74. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.